Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saira Khaderi

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Hepatology International|April 22, 2016
Is response guided therapy dead? Low cure rates in patients with detectable hepatitis C virus at week 4 of treatmentKarla Thornton, Paulina Deming, Richard A Manch, et al.
Transplantation Direct|April 18, 2022
Early Impact of MMaT-3 Policy on Liver Transplant Waitlist Outcomes for Hepatocellular CarcinomaAnjiya Shaikh, Karthik Goli, Nicole E Rich, et al.
Hepatology (Baltimore, Md.)|March 1, 2022
Risk factors for HCC in contemporary cohorts of patients with cirrhosisFasiha Kanwal, Saira Khaderi, Amit G Singal, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2023
Risk Stratification Model for Hepatocellular Cancer in Patients With CirrhosisFasiha Kanwal, Saira Khaderi, Amit G Singal, et al.
Plos One|February 28, 2023
Risk stratification for hepatocellular cancer among patients with cirrhosis using a hepatic fat polygenic risk scoreAaron P Thrift, Fasiha Kanwal, Yanhong Liu, et al.
Hepatology Communications|February 23, 2026
Validation of longitudinal biomarker screening algorithms for HCC detection in patients with cirrhosisAmit G Singal, Qingchun Jin, Jorge Marrero, et al.
Hepatology Communications|December 9, 2024
Serum levels of total bile acids are associated with an increased risk of HCC in patients with cirrhosisHashem B El-Serag, Aaron P Thrift, Hao Duong, et al.
Gut|February 16, 2024
Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosisHashem El-Serag, Fasiha Kanwal, Jing Ning, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 6, 2026
Physician Perspectives on Hepatitis C Treatment During Pregnancy: A Multinational Multispecialty SurveyTatyana Kushner, Maria Buti, Mohamed El-Kassas, et al.
Gastroenterology|November 9, 2024
Phase 3 Validation of PAaM for Hepatocellular Carcinoma Risk Stratification in CirrhosisNaoto Fujiwara, Camden Lopez, Tracey L Marsh, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Hepatology International|April 22, 2016
Is response guided therapy dead? Low cure rates in patients with detectable hepatitis C virus at week 4 of treatmentKarla Thornton, Paulina Deming, Richard A Manch, et al.
Transplantation Direct|April 18, 2022
Early Impact of MMaT-3 Policy on Liver Transplant Waitlist Outcomes for Hepatocellular CarcinomaAnjiya Shaikh, Karthik Goli, Nicole E Rich, et al.
Hepatology (Baltimore, Md.)|March 1, 2022
Risk factors for HCC in contemporary cohorts of patients with cirrhosisFasiha Kanwal, Saira Khaderi, Amit G Singal, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2023
Risk Stratification Model for Hepatocellular Cancer in Patients With CirrhosisFasiha Kanwal, Saira Khaderi, Amit G Singal, et al.
Plos One|February 28, 2023
Risk stratification for hepatocellular cancer among patients with cirrhosis using a hepatic fat polygenic risk scoreAaron P Thrift, Fasiha Kanwal, Yanhong Liu, et al.
Hepatology Communications|February 23, 2026
Validation of longitudinal biomarker screening algorithms for HCC detection in patients with cirrhosisAmit G Singal, Qingchun Jin, Jorge Marrero, et al.
Hepatology Communications|December 9, 2024
Serum levels of total bile acids are associated with an increased risk of HCC in patients with cirrhosisHashem B El-Serag, Aaron P Thrift, Hao Duong, et al.
Gut|February 16, 2024
Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosisHashem El-Serag, Fasiha Kanwal, Jing Ning, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 6, 2026
Physician Perspectives on Hepatitis C Treatment During Pregnancy: A Multinational Multispecialty SurveyTatyana Kushner, Maria Buti, Mohamed El-Kassas, et al.
Gastroenterology|November 9, 2024
Phase 3 Validation of PAaM for Hepatocellular Carcinoma Risk Stratification in CirrhosisNaoto Fujiwara, Camden Lopez, Tracey L Marsh, et al.
Pageof 2